drugset / Trial / NCT01665352
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the safety and effect of TTP054 versus placebo on glucose control in patients with type 2 diabetes.
Timeline
- Start
- 2012-08
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TTP054 | Unknown | 200 mg | Oral |
| Subject | TTP054 | Unknown | 400 mg | Oral |
| Subject | TTP054 | Unknown | 800 mg | Oral |